Please enable JavaScript to continue using this application.

Compare tickers

Valuation, margins, and growth side by side.

Compare $AEMD vs $CTSO | Chartloom

Compare

$AEMD vs $CTSO

Aethlon Medical Inc · Cytosorbents Corp

AEMD

Aethlon Medical Inc

CTSO

Cytosorbents Corp

Compare $AEMD vs $CTSO

Comparing Aethlon Medical Inc and Cytosorbents Corp

AEMDAethlon Medical Inc

CTSOCytosorbents Corp

AEMDAethlon Medical Inc

Market cap

$15M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

96.5%

YTD performance

-60.4%

52W performance

-83.9%

FCF yield

-49.0%

CTSOCytosorbents Corp

Market cap

$217M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

5.02x

Rev growth (TTM)

8.6%

YTD performance

-73.6%

52W performance

-81.1%

FCF yield

-4.5%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

AEMD

CTSO

Detailed metrics comparison

AEMD

Aethlon Medical Inc

CTSO

Cytosorbents Corp

Market Cap

AEMD$15M

CTSO$217M

Enterprise Value

AEMD$10M

CTSO$230M

Price

AEMD$5.58

CTSO$3.46

P/E Ratio

AEMDN/A

CTSON/A

P/S Ratio

AEMD17.03x

CTSO5.84x

EV/Sales

AEMD8.37x

CTSO6.19x

EV/EBITDA

AEMD0.00x

CTSO0.00x

P/B Ratio

AEMD1.87x

CTSO5.44x

P/FCF Ratio

AEMDN/A

CTSON/A

EV/FCF

AEMD-1.35x

CTSO-23.75x

PEG Ratio

AEMDN/A

CTSON/A

Forward P/E (NTM)

AEMDN/A

CTSON/A

Forward P/S (NTM)

AEMDN/A

CTSO5.02x

Revenue (TTM)

AEMD$0

CTSO$37M

Revenue Growth (YoY)

AEMD96.5%

CTSO8.6%

Forward Rev Growth

AEMD170.9%

CTSO13.6%

Gross Margin (TTM)

AEMD0.0%

CTSO71.6%

Operating Margin (TTM)

AEMD0.0%

CTSO0.0%

EBITDA Margin (TTM)

AEMD0.0%

CTSO-28.3%

Net Margin (TTM)

AEMD0.0%

CTSO-48.9%

FCF Margin (TTM)

AEMDN/A

CTSO-26.0%

Net Income (TTM)

AEMD$-7M

CTSO$-18M

FCF (TTM)

AEMD$-7M

CTSO$-10M

EPS (TTM)

AEMD-$18.03

CTSO-$0.29

ROE (TTM)

AEMD-12309.0%

CTSO-16513.0%

ROA (TTM)

AEMD-9929.0%

CTSO-4325.0%

ROIC (TTM)

AEMD-12309.0%

CTSO-5193.0%

Cash

AEMD$5M

CTSO$4M

Debt

AEMD$0

CTSO$17M

Net Cash/Debt

AEMD$5M

CTSO$-13M

Current Ratio (TTM)

AEMD5.42x

CTSO0.66x

Quick Ratio (TTM)

AEMD5.14x

CTSO0.47x

Debt/Equity (TTM)

AEMD0.00x

CTSO7.73x

Debt/Assets (TTM)

AEMD0.0%

CTSO0.0%

Interest Coverage (TTM)

AEMDN/A

CTSON/A

Net Debt/EBITDA (TTM)

AEMD0.00x

CTSO0.00x

Beta

AEMD1.20

CTSO1.51

52W Performance

AEMD-83.9%

CTSO-81.1%

YTD Performance

AEMD-60.4%

CTSO-73.6%

% from 52W High

AEMD-84.5%

CTSO-82.5%

% from 52W Low

AEMD295.7%

CTSO1.1%

Asset Turnover (TTM)

AEMD0.03x

CTSO0.88x

FCF Yield (TTM)

AEMD-49.0%

CTSO-4.5%

Earnings Yield (TTM)

AEMD-47.3%

CTSO-8.4%

Dividend Yield (TTM)

AEMDN/A

CTSON/A

Rule of 40

AEMD96.6

CTSO-17.4

EV/GP/RG

AEMDN/A

CTSO0.53

Ticker research

View AEMD research View CTSO research

Metric	AEMD Aethlon Medical Inc	CTSO Cytosorbents Corp
Market & Valuation
Market Cap	$15M	$217M
Enterprise Value	$10M	$230M
Price	$5.58	$3.46
P/E Ratio	N/A	N/A
P/S Ratio	17.03x	5.84x
EV/Sales	8.37x	6.19x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.87x	5.44x
P/FCF Ratio	N/A	N/A
EV/FCF	-1.35x	-23.75x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	5.02x
Revenue & Growth
Revenue (TTM)	$0	$37M
Revenue Growth (YoY)	96.5%	8.6%
Forward Rev Growth	170.9%	13.6%
Profitability
Gross Margin (TTM)	0.0%	71.6%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-28.3%
Net Margin (TTM)	0.0%	-48.9%
FCF Margin (TTM)	N/A	-26.0%
Net Income (TTM)	$-7M	$-18M
FCF (TTM)	$-7M	$-10M
EPS (TTM)	-$18.03	-$0.29
ROE (TTM)	-12309.0%	-16513.0%
ROA (TTM)	-9929.0%	-4325.0%
ROIC (TTM)	-12309.0%	-5193.0%
Financial Health
Cash	$5M	$4M
Debt	$0	$17M
Net Cash/Debt	$5M	$-13M
Current Ratio (TTM)	5.42x	0.66x
Quick Ratio (TTM)	5.14x	0.47x
Debt/Equity (TTM)	0.00x	7.73x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.20	1.51
52W Performance	-83.9%	-81.1%
YTD Performance	-60.4%	-73.6%
% from 52W High	-84.5%	-82.5%
% from 52W Low	295.7%	1.1%
Efficiency & Yields
Asset Turnover (TTM)	0.03x	0.88x
FCF Yield (TTM)	-49.0%	-4.5%
Earnings Yield (TTM)	-47.3%	-8.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	96.6	-17.4
EV/GP/RG	N/A	0.53
Ticker research	View AEMD research	View CTSO research

Valuation

P/S Ratio

CTSO

5.84x

AEMD

17.03x

EV/FCF

CTSO

-23.75x

AEMD

-1.35x

Growth & revenue

Revenue Growth TTM

AEMD

96.5%

CTSO

8.6%

Forward Revenue Growth

AEMD

170.9%

CTSO

13.6%

Profitability & performance

Gross Margin

CTSO

71.6%

AEMD

0.0%

ROE

AEMD

-12309.0%

CTSO

-16513.0%

FCF Yield %

CTSO

-4.5%

AEMD

-49.0%

52-Week Performance

CTSO

-81.1%

AEMD

-83.9%

Detailed metrics comparison

AEMD

Aethlon Medical Inc

CTSO

Cytosorbents Corp

Market Cap

AEMD$15M

CTSO$217M

Enterprise Value

AEMD$10M

CTSO$230M

Price

AEMD$5.58

CTSO$3.46

P/E Ratio

AEMDN/A

CTSON/A

P/S Ratio

AEMD17.03x

CTSO5.84x

EV/Sales

AEMD8.37x

CTSO6.19x

EV/EBITDA

AEMD0.00x

CTSO0.00x

P/B Ratio

AEMD1.87x

CTSO5.44x

P/FCF Ratio

AEMDN/A

CTSON/A

EV/FCF

AEMD-1.35x

CTSO-23.75x

PEG Ratio

AEMDN/A

CTSON/A

Forward P/E (NTM)

AEMDN/A

CTSON/A

Forward P/S (NTM)

AEMDN/A

CTSO5.02x

Revenue (TTM)

AEMD$0

CTSO$37M

Revenue Growth (YoY)

AEMD96.5%

CTSO8.6%

Forward Rev Growth

AEMD170.9%

CTSO13.6%

Gross Margin (TTM)

AEMD0.0%

CTSO71.6%

Operating Margin (TTM)

AEMD0.0%

CTSO0.0%

EBITDA Margin (TTM)

AEMD0.0%

CTSO-28.3%

Net Margin (TTM)

AEMD0.0%

CTSO-48.9%

FCF Margin (TTM)

AEMDN/A

CTSO-26.0%

Net Income (TTM)

AEMD$-7M

CTSO$-18M

FCF (TTM)

AEMD$-7M

CTSO$-10M

EPS (TTM)

AEMD-$18.03

CTSO-$0.29

ROE (TTM)

AEMD-12309.0%

CTSO-16513.0%

ROA (TTM)

AEMD-9929.0%

CTSO-4325.0%

ROIC (TTM)

AEMD-12309.0%

CTSO-5193.0%

Cash

AEMD$5M

CTSO$4M

Debt

AEMD$0

CTSO$17M

Net Cash/Debt

AEMD$5M

CTSO$-13M

Current Ratio (TTM)

AEMD5.42x

CTSO0.66x

Quick Ratio (TTM)

AEMD5.14x

CTSO0.47x

Debt/Equity (TTM)

AEMD0.00x

CTSO7.73x

Debt/Assets (TTM)

AEMD0.0%

CTSO0.0%

Interest Coverage (TTM)

AEMDN/A

CTSON/A

Net Debt/EBITDA (TTM)

AEMD0.00x

CTSO0.00x

Beta

AEMD1.20

CTSO1.51

52W Performance

AEMD-83.9%

CTSO-81.1%

YTD Performance

AEMD-60.4%

CTSO-73.6%

% from 52W High

AEMD-84.5%

CTSO-82.5%

% from 52W Low

AEMD295.7%

CTSO1.1%

Asset Turnover (TTM)

AEMD0.03x

CTSO0.88x

FCF Yield (TTM)

AEMD-49.0%

CTSO-4.5%

Earnings Yield (TTM)

AEMD-47.3%

CTSO-8.4%

Dividend Yield (TTM)

AEMDN/A

CTSON/A

Rule of 40

AEMD96.6

CTSO-17.4

EV/GP/RG

AEMDN/A

CTSO0.53

Ticker research

View AEMD research View CTSO research

Metric	AEMD Aethlon Medical Inc	CTSO Cytosorbents Corp
Market & Valuation
Market Cap	$15M	$217M
Enterprise Value	$10M	$230M
Price	$5.58	$3.46
P/E Ratio	N/A	N/A
P/S Ratio	17.03x	5.84x
EV/Sales	8.37x	6.19x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.87x	5.44x
P/FCF Ratio	N/A	N/A
EV/FCF	-1.35x	-23.75x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	5.02x
Revenue & Growth
Revenue (TTM)	$0	$37M
Revenue Growth (YoY)	96.5%	8.6%
Forward Rev Growth	170.9%	13.6%
Profitability
Gross Margin (TTM)	0.0%	71.6%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-28.3%
Net Margin (TTM)	0.0%	-48.9%
FCF Margin (TTM)	N/A	-26.0%
Net Income (TTM)	$-7M	$-18M
FCF (TTM)	$-7M	$-10M
EPS (TTM)	-$18.03	-$0.29
ROE (TTM)	-12309.0%	-16513.0%
ROA (TTM)	-9929.0%	-4325.0%
ROIC (TTM)	-12309.0%	-5193.0%
Financial Health
Cash	$5M	$4M
Debt	$0	$17M
Net Cash/Debt	$5M	$-13M
Current Ratio (TTM)	5.42x	0.66x
Quick Ratio (TTM)	5.14x	0.47x
Debt/Equity (TTM)	0.00x	7.73x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.20	1.51
52W Performance	-83.9%	-81.1%
YTD Performance	-60.4%	-73.6%
% from 52W High	-84.5%	-82.5%
% from 52W Low	295.7%	1.1%
Efficiency & Yields
Asset Turnover (TTM)	0.03x	0.88x
FCF Yield (TTM)	-49.0%	-4.5%
Earnings Yield (TTM)	-47.3%	-8.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	96.6	-17.4
EV/GP/RG	N/A	0.53
Ticker research	View AEMD research	View CTSO research